Natural products have gained attention as potential treatments for diabetes, with algae emerging as a rich source of bioactive compounds. Sea algae contain various health-promoting molecules such as carotenoids, polysaccharides, fatty acids, amino acids, polyphenols, tocopherols, pigments, proteins, and omega-3 fatty acids. These compounds offer anti-diabetic effects by improving insulin sensitivity, regulating glucose metabolism, and combating oxidative stress. As a result, algae are widely used in medications, cosmetics, dietary supplements, and functional foods. Clinical studies have examined the glycemic control benefits of both microalgae and macroalgae species like Spirulina, Chlorella, Dunaliella, and Haematococcus pluvialis in diabetic patients. The increasing preference for natural remedies among consumers emphasizes the potential of algae-based solutions in managing diabetes. Additionally, patents involving algae-derived formulations and innovative extraction methods support their increasing role in pharmaceutical and nutraceutical development. Combining clinical research with patented technologies strengthens the case for algae-based interventions in diabetes management.